12:32 PM EST - InMed Pharmaceuticals Inc. : Reported financial results for the three months ended September 30, 2018, which is the Company's first quarter of fiscal year 2019. For 1Q19, the Company recorded a comprehensive net loss of $2.8 million, or $0.02 per share, compared with a comprehensive net loss of $1.8 million, or $0.01 per share, for the three months ended September 30, 2017. InMed Pharmaceuticals Inc.
shares T.IN are trading down $0.07 at $0.59.
